Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56.1M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
39.9M
-
Shares change
-
+3.63M
-
Total reported value, excl. options
-
$379M
-
Value change
-
+$36.8M
-
Put/Call ratio
-
0.55
-
Number of buys
-
104
-
Number of sells
-
-47
-
Price
-
$9.51
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q3 2025
185 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2025.
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.9M shares
of 56.1M outstanding shares and own 71.11% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (4.04M shares), Woodline Partners LP (3.48M shares), VANGUARD GROUP INC (3.08M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.23M shares), Nantahala Capital Management, LLC (1.97M shares), FMR LLC (1.63M shares), STATE STREET CORP (1.43M shares), GEODE CAPITAL MANAGEMENT, LLC (1.3M shares), AIGH Capital Management LLC (1.23M shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.21M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.